Lunit Inc. (328130) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lunit Inc. (328130:KRX), powered by AI.

Current Price
₩32,650
P/E Ratio
-11.4
Market Cap
953.5B
Sector
Healthcare
What is the Lunit Inc. stock price forecast?

Lunit Inc. is currently trading at ₩32,650. View real-time AI analysis on Alpha Lenz.

What is Lunit Inc. insider trading activity?

View the latest insider trading data for Lunit Inc. on Alpha Lenz.

What is Lunit Inc.'s P/E ratio?

Lunit Inc.'s P/E ratio is -11.4.

Lunit Inc.

₩32.65K
KRX328130
Ask about Lunit Inc.'s future dividend policy...
Alpha Chat Insight

Lunit Inc. trades at a P/E of -11.4 (undervalued) with modest ROE of -41.2%. 3Y revenue CAGR of 101.3% highlights clear growth momentum.

Ask for details

Company Overview

Lunit Inc. is a pioneering entity in the field of medical artificial intelligence. The company specializes in developing advanced AI-powered diagnostic solutions aimed at enhancing the accuracy and efficiency of medical imaging processes. Lunit Inc.’s core products focus on areas such as radiology and oncology, providing tools that assist healthcare professionals in detecting diseases like cancer more accurately and at earlier stages. These innovations are pivotal in sectors such as hospitals, diagnostic centers, and research institutions, significantly impacting the overall healthcare ecosystem by improving patient outcomes and streamlining clinical workflows. Lunit Inc. continually collaborates with global healthcare institutions and technology firms to integrate its AI solutions into existing medical systems. Headquartered in Seoul, South Korea, the company holds a vital role in the intersection of healthcare and technology, pushing advancements in AI applications for medical diagnostics and shaping future healthcare delivery models through cutting-edge machine learning techniques.

CEO서범석
SectorHealthcare
IndustryHealth Information Services
Employees298

Company Statistics

(FY 2024)

Profile

Market Cap₩953.53B
Revenue₩54.18B
Shares Out29.20M
Employees298

Margins

Gross100.00%
EBITDA-96.95%
Operating-124.93%
Pre-Tax-153.61%
Net-152.13%

Valuation

P/E-11.42
P/B5.71
EV/Sales17.38
EV/EBITDA-18.31
P/FCF-13.01

Growth (CAGR)

Rev 3Yr101.33%
Rev 5Yr207.08%
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-23.45%
ROE-41.21%
ROIC-19.78%

Financial Health

Cash & Cash Equivalents₩52.37B
Net Debt₩217.81B
Debt/Equity163.88%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Lunit Inc. (Healthcare) Stock Forecast & Analysis ₩32,650 | Alpha Lenz